Buprenorphine treatment is a type of medication-assisted treatment for opioid use disorder. It uses buprenorphine, a prescription medicine, to ease withdrawal and cravings so daily life feels more stable. At Health Care Resource Centers, you will receive buprenorphine treatment in a structured, office-based program with ongoing support.
Buprenorphine is a medication used to treat opioid use disorder. It is a partial opioid agonist, so it activates opioid receptors but less than heroin, fentanyl, or many pain pills. This helps reduce cravings and withdrawal without the same intense high.
Â
Buprenorphine is found in medications such as Suboxone, Sublocade, and Zubsolv. Some products combine buprenorphine and naloxone to lower the risk of misuse. Your provider will help you choose the form that fits your needs and routine.
When used as part of a MAT program, buprenorphine treatment can offer:
Reduced cravings and withdrawal so you feel more stable
Simple dosing, often once or twice a day
Lower overdose risk than uncontrolled opioid use
Better chances of staying in counselling and care
Treatment that fits daily life for many patients
At HCRC, you will receive buprenorphine treatment through office-based opioid treatment programs. These OBOT visits feel like regular doctor appointments but follow a clear medication-assisted treatment plan.
Â
After an assessment, your provider may prescribe a buprenorphine or buprenorphine/naloxone medication, such as Suboxone. You pick up your medicine at a local pharmacy, take it as directed at home, and return for follow-up visits, so your team can support your progress.
In our programs, buprenorphine treatment follows a simple process:
You meet with a provider to review health, substance use, and goals
You and your provider agree on a MAT plan with buprenorphine
You learn when to start, how often to take it, and what to expect
You attend regular visits so your dose and care plan stay safe
Buprenorphine has a ceiling effect, so taking more than prescribed does not create unlimited euphoria. This feature helps lower overdose risk within a medication-assisted treatment plan.
Buprenorphine and methadone are both used in opioid treatment programs. Both can reduce cravings and withdrawal and support long-term recovery.
Â
If you are unsure about buprenorphine vs methadone, your provider will review your history and help you choose the option that fits you best.
Buprenorphine treatment usually follows several phases in a MAT program:
1
Induction: You start buprenorphine after a short time without opioids to ease early withdrawal
2
Stabilization: Your opioid use decreases, cravings lessen, and you feel steadier
3
Maintenance: You stay on a stable dose for as long as needed for recovery
4
Taper: You and your team may later decide to lower the dose slowly when you are ready
Throughout each phase, you will receive regular check-ins and support to keep care safe and effective.
You may be a good fit for buprenorphine treatment if you:
Â
Â
Â
A medical provider will review your health history, current medicines, and other conditions before starting buprenorphine. Buprenorphine treatment may be a better option than methadone when daily clinic visits are hard or when certain medical issues make methadone less suitable.
Buprenorphine based medication assisted treatment offers a practical way to treat opioid use disorder and support long-term stability. At Health Care Resource Centers, you will receive OBOT care with buprenorphine, counseling, and regular follow-up, all in a respectful, clinic-style setting. Our team will help you build a clear plan that fits your life and goals.
All HCRC centers are federally certified, state licensed, and accredited by the Commission on Accreditation of Rehabilitation Facilities (CARF). This recognition reflects our commitment to safety, quality, and continuous improvement.
Buprenorphine treatment uses a regular prescribed dose of buprenorphine, often Suboxone or another buprenorphine/naloxone medicine, as part of a MAT program for opioid use disorder. You also receive support such as counselling and follow-up visits.
Buprenorphine is a partial opioid agonist that attaches to the same brain receptors as opioids but activates them less. This helps control cravings and withdrawal so you can focus on recovery and daily life.
Common side effects can include nausea, constipation, headache, or sleep changes, especially when you first start or change doses. Your provider will explain what to watch for and adjust your dose if needed.
Both are used in MAT programs, but buprenorphine is a partial agonist with a ceiling effect and is often prescribed in office-based settings, while methadone is a full agonist usually given in specialized clinics. Your provider can help you decide which option fits you.
There is no single length of time. Some people stay on buprenorphine treatment for several years, while others taper sooner when they feel stable and supported. You and your team decide together.
Contact a clinic or OBOT provider that offers medication-assisted treatment. You will receive an assessment, learn about buprenorphine treatment, and get clear next steps for starting a MAT program at HCRC or another qualified program.
